Correction: Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir

Correction to: Signal Transduction and Targeted Therapy 10.1038/s41392-025-02207-w, published online 11 April 2025

After online publication of the article,¹ the authors noticed inadvertent errors in the Materials and Methods section. In the “In vitro viral inhibition assays” subsection, the sentence “The solvent was used as the non-treated control.” has been corrected to “Infected cells treated with solvent only were used as the virus control, and uninfected cells treated with solvent only were used as the non-treated control.” The formula “Inhibition rate (%) = (drug treated well - blank) - (non-treated control well - blank) × 100%” has been corrected to “Inhibition rate (%) = [1 - (non-treated control well - drug-treated well)/(non-treated control well - virus control well)] × 100%.” In the “Histological examination” subsection, the misspelled word “aera” has been corrected to “area”.

In addition, the layout of the P value symbols in Figure 3b, Figure 4b, Figure 4c, Figure 4g, and Figure 5c was adjusted for alignment and clarity only, no numerical values, statistical analyses, or figure contents were changed.

Figure 3 Incorrect

Figure 3 Corrected

Figure 4 Incorrect

Figure 4 Corrected

Figure 5 Incorrect

Figure 5 Corrected

These corrections do not affect the results, interpretations, or conclusions of the study.